In its August announcement, FDA's Center for Biologics Evaluation and Research (CBER) pointed to more than 20 cases of ...

French drugmaker Valneva said on Monday it has voluntarily withdrawn its application seeking standard approval of its ...

Valneva SE ADR (NASDAQ:VALN) shares dropped 6.6% in premarket trading on Tuesday after the vaccine maker said it has ...

Company voluntarily withdraws IXCHIQ BLA and IND in the U.S. Continuing review of global product opportunity according to medical need and ...

The decision comes months after the FDA had suspended the vaccine’s license. One analyst speculated the company might shelve the product altogether.

Valneva withdrew its chikungunya vaccine applications following a license suspension and data suggesting a probable link to serious adverse outcomes.

With an FDA accelerated approval in November 2023, Ixchiq became the world’s first shot for chikungunya. Its retreat leaves Bavarian Nordic’s Vimkunya the only available chikungunya vaccine in the U.S ...

With Chikungunya continuing to leave thousands of Indians with prolonged and debilitating joint pain, the Indian Council of ...

The US Centers for Disease Control and Prevention is currently investigating five hospitalizations that occurred in people who had recently received a vaccine that prevents disease caused by the ...

The chikungunya fever outbreak is heating up. U.S. health officials on Thursday confirmed two locally acquired cases of chikungunya in Florida. In Puerto Rico, the government has declared an epidemic ...

The country has been battling chikungunya and dengue over the past few months, with the national capital reporting nearly 30 deaths linked to the illnesses, and over 2,800 people reported infected. In ...

The chikungunya virus, a mosquito-borne illness that causes high fevers and sometimes intense pain, is spreading rapidly throughout the Caribbean. Now, numerous cases of the disease have appeared in ...